Alexandria Real Estate Equities
ARE
NZ$121.09
Share price
-0.19%
Change (1 day)
-34.47%
Change (1 year)
Categories
Alexandria Real Estate Equities, Inc. is a real estate investment trust that invests in office buildings and laboratories.
EPS for Alexandria Real Estate Equities (ARE)
EPS in 2025 (TTM): NZ$3.43
According to Alexandria Real Estate Equities 's latest financial reports the company's current EPS (TTM) is NZ$3.49. In 2022 the company made an earnings per share (EPS) of NZ$5.18 a decrease over its 2021 EPS that were of NZ$6.27.
EPS history for Alexandria Real Estate Equities from 2012 to 2025
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2025 (TTM) | NZ$3.43 | |
| 2022 | NZ$5.18 | -17.41% |
| 2021 | NZ$6.27 | -35.32% |
| 2020 | NZ$9.69 | 89.03% |
| 2019 | NZ$5.13 | -12.68% |
| 2018 | NZ$5.87 | |
| 2014 | NZ$1.67 | -36.88% |
| 2013 | NZ$2.65 | 46.79% |
| 2012 | NZ$1.80 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | NZ$2.30 | -34.12% | 🇺🇸 USA |
 Gilead Sciences GILD | NZ$7.91 | 126.54% | 🇺🇸 USA |
 Eli Lilly LLY | NZ$20.44 | 485.59% | 🇺🇸 USA |
 Illumina ILMN | NZ-$10.01 | -386.73% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | NZ$4.43 | 27.01% | 🇺🇸 USA |
 Amgen AMGN | NZ$18.28 | 423.70% | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | NZ-$3.24 | -192.89% | 🇺🇸 USA |